-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Twzr4R2JXxulrPOvoxua0uU6yefoVTLbDXtjCPHTPBgz/aohuly37zTqvhindpVo rLdyw0Sycfhs0gFn04Pb8Q== 0001278569-06-000001.txt : 20060316 0001278569-06-000001.hdr.sgml : 20060316 20060316171515 ACCESSION NUMBER: 0001278569-06-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20060314 FILED AS OF DATE: 20060316 DATE AS OF CHANGE: 20060316 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BAXTER INTERNATIONAL INC CENTRAL INDEX KEY: 0000010456 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 360781620 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BAXTER PKWY STREET 2: DF2-2W CITY: DEERFIELD STATE: IL ZIP: 60015 BUSINESS PHONE: 8479482000 MAIL ADDRESS: STREET 1: ONE BAXTER PARKWAY STREET 2: DF2-2W CITY: DEERFIELD STATE: IL ZIP: 60015 FORMER COMPANY: FORMER CONFORMED NAME: BAXTER TRAVENOL LABORATORIES INC DATE OF NAME CHANGE: 19880522 FORMER COMPANY: FORMER CONFORMED NAME: BAXTER LABORATORIES INC DATE OF NAME CHANGE: 19760608 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GREISCH JOHN J CENTRAL INDEX KEY: 0001278569 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-04448 FILM NUMBER: 06693008 BUSINESS ADDRESS: BUSINESS PHONE: 8479483980 MAIL ADDRESS: STREET 1: C/O ANITA OAS BAXTER INTERNATIONAL INC. STREET 2: ONE BAXTER PARKWAY CITY: DEERFIELD STATE: IL ZIP: 60015 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2006-03-14 0000010456 BAXTER INTERNATIONAL INC BAX 0001278569 GREISCH JOHN J ONE BAXTER PARKWAY DEERFIELD, IL 60015 0 1 0 0 Corporate Vice President & CFO Common Stock, $1 par value 2006-03-14 4 A 0 27000 A 76082 D Common Stock, $1 par value 2006-03-14 4 F 0 2872 38.35 D 73210 D Stock Option (Right to Buy) 38.35 2006-03-14 4 A 0 180000 0 A 2009-03-14 2016-03-14 Common Stock, $1 par value 180000 180000 D On March 14, 2006, the reporting person received a grant of 27,000 restricted stock units of common stock which will vest as follows: 9,000 on March 14, 2007; 9,000 on March 14, 2008; and 9,000 on March 14, 2009. /s/David P. Scharf, Attorney-in-Fact for John J. Greisch 2006-03-16 EX-24 2 greischpoa3-2006.htm 
POWER OF ATTORNEY



          Know all by these presents, that the undersigned hereby constitutes and appoints each of Susan R. Lichtenstein, Robert M. Davis and David P. Scharf, signing singly, the undersigned's true and lawful attorney-in-fact to:

(1)        execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of Baxter International Inc., Baxter Healthcare Corporation or Baxter World Trade Corporation (collectively "Baxter") Forms 3, 4, 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder and Form 144 under Rule 144 under the Securities Act of 1933;

(2)        do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, 5, or 144 and complete and execute any amendment or amendments thereto, and timely file any such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

(3)        take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

 The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is Baxter assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934 and Rule 144 of the Securities Act of 1933.

          This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, 5 and 144 with respect to the undersigned's holdings of and transactions in securities issued by Baxter, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 6th day of March, 2006.



      ___________________________________

              John J. Greisch
-----END PRIVACY-ENHANCED MESSAGE-----